Tenaya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (TNYA)

Historical Holders from Q3 2021 to Q1 2025

Symbol
TNYA on Nasdaq
CUSIP
87990A106
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
157M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
43.6M
Holdings value
$62.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
82
Number of buys
41
Number of sells
-46
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tenaya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (TNYA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
COLUMN GROUP III, LP 32% $28.1M 49.3M The Column Group Opportunity III, LP Mar 5, 2025
Casdin Capital, LLC 4.3% $3.84M 6.73M Casdin Capital, LLC Mar 4, 2025
BlackRock, Inc. 6.7% $3.02M 5.3M BlackRock, Inc. Dec 31, 2024
JPMORGAN CHASE & CO 2.8% -52.9% $1.3M -$1.64M 2.28M -55.7% JPMORGAN CHASE & CO. Feb 28, 2025

Institutional Holders of Tenaya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (TNYA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 266K $151K +$54.2K $0.57 9
2024 Q4 43.6M $62.3M -$25.9M $1.43 82
2024 Q3 57.6M $111M +$67K $1.93 91
2024 Q2 56.9M $176M +$2.25M $3.10 93
2024 Q1 56M $293M +$50.7M $5.23 89
2023 Q4 46.6M $151M -$9.69M $3.24 73
2023 Q3 49.7M $127M -$3.32M $2.55 76
2023 Q2 47.7M $280M +$15.9M $5.87 79
2023 Q1 45M $128M -$2.29M $2.85 65
2022 Q4 47.1M $94.7M +$23M $2.01 66
2022 Q3 35.2M $102M -$12.3M $2.90 65
2022 Q2 37M $209M -$1.85M $5.63 45
2022 Q1 37.3M $440M +$23.6M $11.78 48
2021 Q4 35.4M $668M +$18.4M $18.95 46
2021 Q3 33.9M $693M +$693M $20.65 46